- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
New approaches for finding tiny tumors: Towards early detection and treatment of ovarian cancer
Angela M. Belcher
Massachusetts Institute of Technology, Cambridge, MA, United States
- Permission not
granted for presentation
Breast cancer intratumor heterogeneity landscapes: What, when, and where
Carlos M. Caldas
Cancer Research UK Cambridge Inst., Cambridge, United Kingdom
- Free
- slides video
- audio + slides
- All slides included
Earlier detection as a key to lower cancer death rates
Bert Vogelstein
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
- Free
- slides video
- audio + slides
- All slides included
New twists on cancer drug resistance
Charles L. Sawyers
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
- Permission not
granted for presentation
Immune checkpoint blockade in cancer therapy: Insights, opportunities, and prospects for cures
James P. Allison
UT MD Anderson Cancer Ctr., Houston, TX, United States
- Permission not
granted for presentation
Microbiome and cancer therapies
Laurence Zitvogel
Gustave Roussy Cancer Center, Villejuif, France
- Free
- podium video
- audio + slides
- Some slides withheld
Genetically engineered T cells for cancer
Crystal L. Mackall
Stanford University, Stanford, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Cell states linked to immunotherapy response and resistance
Levi A. Garraway
Eli Lilly and Company, Indianapolis, IN, United States
- Free
- Unknown permission
for presentation
Leveraging premalignant biology for immune-based cancer prevention
Scott M. Lippman
UCSD Moores Cancer Ctr., La Jolla, CA, United States
- Free
- slides video
- audio + slides
- All slides included
Precision medicine and cancer health disparities
Chanita Hughes-Halbert
Medical Univ. of SC Hollings Cancer Ctr., Charleston, SC, United States
- Free
- slides video
- audio + slides
- All slides included
Precision medicine lessons from window-of-opportunity trials
Jennifer Rubin Grandis
UCSF, San Francisco, CA, United States
- Free
- Coming soon
- Some slides withheld
Drug resistance: Tailoring therapies to mechanisms to improve outcomes
Alice T. Shaw
Massachusetts General Hosp. Cancer Ctr., Boston, MA, United States
- Free
- slides video
- audio + slides
- All slides included
G-quadruplexes and DNA dynamics
Shankar Balasubramanian
University of Cambridge, Cambridge, United Kingdom
- Free
- podium video
- audio + slides
- Some slides withheld
Activity-based biomarkers for noninvasive cancer detection
Sangeeta N. Bhatia
Massachusetts Institute of Technology, Cambridge, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Novel approaches for personalizing treatments: From nutrition to cancer
Eran Segal
Weizman Institute of Science, Rehovot Israel, Israel
- Free
- Unknown permission
for presentation
Mathematical modeling of cancer evolution
Franziska Michor
Dana-Farber Cancer Institute, Boston, MA, United States
- Free
- podium video
- audio + slides
- Some slides withheld
Basic science and translational implications
Kornelia Polyak
Dana-Farber Cancer Inst., Boston, MA, United States
- Free
- slides video
- audio + slides
- All slides included
Therapeutics
Elizabeth M. Jaffee
Johns Hopkins Kimmel Comp. Cancer Ctr., Baltimore, MD, United States
- Free
- podium video
- audio + slides
- Some slides withheld
Early detection and prevention research
Nancy E. Davidson
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
- Free
- podium video
- audio + slides
- All slides included
Wrap-up and vision for the future
Michael A. Caligiuri
James Cancer Hospital & Solove Res. Inst., Columbus, OH, United States